Project Grant R01HL174511
Award Date
8/1/25
Completion Date
4/30/29
Dollars Obligated
$732K
Federal Agency
National Heart Lung and Blood Institute
Awardee
Cleveland Clinic Lerner College Of Medicine Of Case Western Reserve University (M5QFLTCTSQN6)
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Cleveland, OH 44195, USA
Similar Awards
This $177,403 Project Grant was awarded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research (CFDA 93.837) program. The funding supports research to disentangle the heterogeneity of asthma, identify distinct asthma endotypes, and investigate biological mechanisms underlying established risk factors. The project will utilize multi-omics data from three cohorts of asthmatic children to analyze the interplay between genetic, epigenetic, and metabolomic...
This federal Project Grant award for $2,016,357 from the National Heart Lung and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) supports research by Mayo Clinic to investigate the role of Transmembrane Protein 178 (TMEM178) as a novel endogenous inhibitory mechanism in asthma. The research aims to characterize how TMEM178 regulates calcium responses and inflammation in bronchial epithelial cells, and assess the impact of TMEM178 genetic variants on asthma severity. The...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) provides $616,814 to the President and Fellows of Harvard College, Harvard T.H. Chan School of Public Health, to conduct research on the role of microRNAs in regulating airway smooth muscle function and their contribution to asthma. The overarching goal is to establish the in vivo impact of key microRNAs in regulating airway smooth muscle proliferation,...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $777,497.00 to The Washington University to study how the circadian clock mediates the adult age, pro-resolution response to viral asthma triggers. The research aims to clarify how the circadian clock operating within alveolar macrophages and airway epithelial cells promotes the resolution of viral inflammation and normal repair...
This Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) provides $740,709 to the University of Utah to conduct research on how early-life viral infections can lead to the development of childhood asthma. The key objectives are to define the cellular and molecular mechanisms by which viral-induced inflammation programs hyperactivated type 2 innate lymphoid cells (ILC2s) in the lung, and determine if these hyperactivated ILC2s...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under CFDA Program 93.837 - Cardiovascular Diseases Research, will provide $246,000.00 to the University of Chicago to investigate the immune cell landscape in Amish and Hutterite children and its relationship to asthma risk. The researchers will leverage the natural environmental differences between these two farming populations to generate multi-omic datasets characterizing the transcriptional and...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $458,634 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Cincinnati. The goal of this 2-year project (8/1/2025 - 7/31/2027) is to conduct a multi-ancestry genome-wide association analysis and develop polygenic risk scores to identify genetic variants specifically associated with moderate-to-severe asthma, which accounts for a significant portion of...
The National Heart, Lung, and Blood Institute (NHLBI), under CFDA 93.837 - Cardiovascular Diseases Research, awarded a $387,116 Project Grant to the University of South Florida. The 5-year grant, effective May 1, 2025, supports research to define the neural mechanisms by which house dust mite (HDM) exposure triggers airway hyperreactivity, a key characteristic of asthma. The research aims to identify the specific sensory nerve subtypes and signaling pathways activated by HDM that lead to...
This Project Grant award for $355,935 from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research federal grant program (CFDA 93.837) supports the development of a novel, oral immunoregulatory therapeutic for the treatment of asthma. The primary objectives are to characterize the therapeutic efficacy and dosing regimen of the compound in mouse models of asthma, and to evaluate its ability to modulate immune function and suppress inflammation in human...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $249,000 to Brigham & Women's Hospital Inc. to develop methodologies to reveal the role of the blood microbiome in the gut-lung axis for asthma pathogenesis. The project aims to create a strain-resolved computational pipeline for reduced metagenomic sequencing to profile the blood microbiome, and a deep-learning framework to...